ACTRN12618000073202已完成4 期
Cefazolin as an alternative to vancomycin for late onset sepsis in preterm infants; A randomised controlled pilot trial.
John Hunter Childrens Hospital0 个研究点目标入组 12 人开始时间: 2018年1月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 72 Hours 至 16 Weeks（—）
- 性别
- All
入选标准
- •Signed, written informed consent by a parent or a legal guardian
- •Infants <29 weeks gestation at birth
- •Baby starting treatment for an episode of suspected LOS
- •Postnatal age more than 72 hours and less than term corrected gestational age (at time of suspected LOS).
排除标准
- •Presence of major congenital malformation(s) or chromosomal abnormalities
- •Contraindications for either antibiotic regimen
研究者
相似试验
招募中
2 期
Prophylactic effect of cefazolin-vancomycin versus ceftazidime-vancomycin on the infection of surgical site in patients undergoing open heart surgerySurgical wound infection.Infection of obstetric surgical woundO86.0IRCT20120215009014N324Hamedan University of Medical Sciences434
进行中（未招募）
不适用
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/AEUCTR2004-005159-32-DEPfizer Pharma GmbH332
进行中（未招募）
1 期
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/ACatheter-related Gram-positive bloodstream infections.MedDRA version: 7.1Level: LLTClassification code 10007810EUCTR2004-005159-32-SKPfizer Limited322
进行中（未招募）
1 期
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/AEUCTR2004-005159-32-ESPfizer, S.A332
招募中
3 期
effect of cefazolin prophylaxis in TUL surgeryIRCT20160514027893N2Bojnourd University of Medical Sciences98